학술논문
The sequential natalizumab – alemtuzumab therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS) trial – Part I: Rationale and objectives
Document Type
Review
Author
Source
In: Journal of Central Nervous System Disease . (Journal of Central Nervous System Disease, August 2022, 14)
Subject
Language
English
ISSN
11795735